Speaker illustration

Doctor Alessandra Rossini

University of Milan - Department of Pharmacological Sciences and Bio, Milan (Italy)

Mitochondrial players as novel therapeutic options in arrhythmogenic cardiomyopathy

Date: 29 May 2024

Journal: Cardiovascular Research

Thumbnail

Set-up of a novel in vitro neurocardiac cell model for the in-depth study of heart disease

Date: 10 June 2022

Journal: Cardiovascular Research

Thumbnail

Evidence of mitochondrial alterations in primary cardiac stromal cells from arrhythmogenic cardiomyopathy hearts

Date: 10 June 2022

Journal: Cardiovascular Research

Thumbnail

Are human induced pluripotent stem cell derived cardiomyocytes a good cellular model for studying incomplete penetrance in arrhythmogenic cardiomyopathy?

Date: 10 June 2022

Journal: Cardiovascular Research

Thumbnail

ESC 365 is supported by